Halozyme Therapeutics
HALO
#2057
Rank
NZ$13.13 B
Marketcap
$106.66
Share price
0.28%
Change (1 day)
59.02%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): $2.86

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is $3.04. In 2022 the company made an earnings per share (EPS) of $2.59 a decrease over its 2021 EPS that were of $4.98.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.8610.74%
2022$2.59-48.07%
2021$4.98196.88%
2020$1.68-292%
2019-$0.87-9.09%
2018-$0.96-237.5%
2017$0.70-149.38%
2016-$1.41211.54%
2015-$0.45-52.73%
2014-$0.96-24.66%
2013-$1.2848.98%
2012-$0.86145%
2011-$0.35-64.29%
2010-$0.98-17.65%
2009-$1.199.68%
2008-$1.0893.75%
2007-$0.5633.33%
2006-$0.42-4%
2005-$0.44-3.85%
2004-$0.45-13.33%
2003-$0.5283.59%
2002-$0.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.33-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.48 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.94 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.25 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.56 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
$24.60 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA